🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsTirzepatide (Mounjaro / Zepbound)Has anyone dealt with tirzepatide and muscle preservation? Page 7

Has anyone dealt with tirzepatide and muscle preservation?

marcus_mpls Thu, Oct 31, 2024 at 4:36 AM 50 replies 2,916 viewsPage 7 of 10
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Feb 21, 2025 at 11:43 AM#31

Adding the numbers, since they settle part of this. If you are going to change something, change one thing and give it long enough to express itself. Four weeks is the usual minimum for anything pharmacological on this board, and two weeks of data has told you almost nothing.

18 16steve_okc, dave_SLC, FDA_TrackerJim and 15 others
Reply Quote Save Share Report
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Mar 2, 2025 at 10:07 AM#32

Following on from sarah_TO — and this may be the naive question:

Did your prescriber agree with that reading, and if not what was their objection?

19 17andrew_nyc, Dr.EndoEP, GraceAZ_72 and 16 others
Reply Quote Save Share Report
dave_SLC
Member
345
1,567
Aug 2024
Salt Lake City, UT
Mar 11, 2025 at 8:26 AM#33
kate.chem said:
If you are going to change something, change one thing and give it long enough to express itself.

I read this differently. The confidence in this thread is running ahead of the evidence, and I would rather the uncertainty were stated than smoothed over because it is unsatisfying.

20 18james_edin, FranDenver, Dr.BariatricHTX and 17 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
mia_MS2
New Member
8
23
Jun 2026
Ann Arbor, MI
Mar 20, 2025 at 6:40 AM#34
kate.chem said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right for the common case. Whether it is right for the case being asked about depends on a detail that has not been given.

Last edited: Mar 20, 2025 at 9:40 AM
21 19steve_okc, dave_SLC, FDA_TrackerJim and 18 others
Reply Quote Save Share Report
nick_SD_fit
Member
278
1,234
Sep 2024
San Diego, CA
Mar 29, 2025 at 4:49 AM#35
kate.chem said:
If you are going to change something, change one thing and give it long enough to express itself.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

22 20SurmountFan_IN, PeptideChemSF, A1cHero_PHX and 19 others
Reply Quote Save Share Report

Similar Threads

SURMOUNT-5: Tirzepatide vs semaglutide head-to-head — full results11 replies
SURPASS 1-5 program: tirzepatide T2DM efficacy data compilation6 replies
Tirzepatide dual agonism: GIP + GLP-1 synergistic mechanism18 replies
5mg → 10mg → 15mg titration — clinical guidance and real-world data8 replies
Zepbound insurance coverage — payer-by-payer breakdown 20268 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register